These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6397 related articles for article (PubMed ID: 3146902)

  • 41. A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinoma.
    Bakács T; Lee J; Moreno MB; Zacharchuk CM; Cole MS; Tso JY; Paik CH; Ward JM; Segal DM
    Int Immunol; 1995 Jun; 7(6):947-55. PubMed ID: 7577803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat.
    Quan N; Zhang Z; Demetrikopoulos MK; Kitson RP; Chambers WH; Goldfarb RH; Weiss JM
    Cancer Res; 1999 Mar; 59(5):1080-9. PubMed ID: 10070966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary Tumors Limit Metastasis Formation through Induction of IL15-Mediated Cross-Talk between Patrolling Monocytes and NK Cells.
    Kubo H; Mensurado S; Gonçalves-Sousa N; Serre K; Silva-Santos B
    Cancer Immunol Res; 2017 Sep; 5(9):812-820. PubMed ID: 28811289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
    Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
    Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Major histocompatibility complex regulation of the class of the immune response: the H-2d haplotype determines poor interferon-gamma response to several antigens.
    Asherson GL; Dieli F; Gautam Y; Siew LK; Zembala M
    Eur J Immunol; 1990 Jun; 20(6):1305-10. PubMed ID: 2114997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expression.
    Tilkin-Mariamé AF; Cormary C; Ferro N; Sarrabayrouse G; Lajoie-Mazenc I; Faye JC; Favre G
    FASEB J; 2005 Sep; 19(11):1513-5. PubMed ID: 15990392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired tumor phenotypes in class II major histocompatibility complex antigen-inducible cells originated from human lung adenocarcinoma.
    Kawamoto S; Inoue Y; Shinozaki Y; Katakura Y; Tachibana H; Shirahata S; Murakami H
    Biochem Biophys Res Commun; 1995 Oct; 215(1):280-5. PubMed ID: 7575602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of the incidence of metastasis in tumor-resected mice. Influence of soluble tumor extract and splenectomy.
    Klein S; de Bonaparte YP; de D'Elia I
    Invasion Metastasis; 1985; 5(5):309-16. PubMed ID: 4030247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
    Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
    Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.
    Garrido G; Rabasa A; Garrido C; López A; Chao L; García-Lora AM; Garrido F; Fernández LE; Sánchez B
    Oncogene; 2014 Jun; 33(24):3129-39. PubMed ID: 23975426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the expression of H-2 and H-2-linked antigens on mammary tumor cells.
    Snoek M; Démant P
    Int J Cancer; 1979 Aug; 24(2):165-7. PubMed ID: 90659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN
    J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytogenetic orientation of the rat major histocompatibility complex (MHC) on chromosome 20.
    Helou K; Walter L; Günther E; Levan G
    Immunogenetics; 1998; 47(2):166-9. PubMed ID: 9396863
    [No Abstract]   [Full Text] [Related]  

  • 55. Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells.
    Giacomini P; Aguzzi A; Ferrone S
    Hybridoma; 1986; 5(4):277-88. PubMed ID: 3100420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines.
    Koch KS; Son KH; Maehr R; Pellicciotta I; Ploegh HL; Zanetti M; Sell S; Leffert HL
    Immunology; 2006 Sep; 119(1):98-115. PubMed ID: 16836618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
    Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
    Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes.
    Musiani P; Modesti A; Brunetti M; Modica A; Vitullo P; Gulino A; Bosco MC; Colombo MP; Nanni P; Cavallo F
    Nat Immun; 1994; 13(2-3):93-101. PubMed ID: 8173240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation by MHC class I antigens of the biology of melanoma cells. Non-immunological mechanisms.
    Gattoni-Celli S; Calorini L; Simile MM; Ferrone S
    Melanoma Res; 1993 Aug; 3(4):285-9. PubMed ID: 8219762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perforin is a major contributor to NK cell control of tumor metastasis.
    Smyth MJ; Thia KY; Cretney E; Kelly JM; Snook MB; Forbes CA; Scalzo AA
    J Immunol; 1999 Jun; 162(11):6658-62. PubMed ID: 10352283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 320.